Repository logo
 
Publication

Implementation of a Nationwide Surveillance Network of Respiratory Syncytial Virus in Children < 2 years old in Portugal

dc.contributor.authorMelo, Aryse
dc.contributor.authorTorres, Ana Rita
dc.contributor.authorLança, Miguel
dc.contributor.authorGaio, Vânia
dc.contributor.authorRodrigues, Ana Paula
dc.contributor.authorGuiomar, Raquel
dc.contributor.authorBandeira, Teresa
dc.contributor.authorAzevedo, Inês
dc.contributor.authorVigiRSV network
dc.date.accessioned2024-02-08T15:54:55Z
dc.date.available2024-02-08T15:54:55Z
dc.date.issued2023-05-09
dc.description.abstractHuman respiratory syncytial virus (RSV) is associated with substantial morbidity and mortality in infants, young children and elderly. Monoclonal antibodies (MAb) therapy is the available method to prevent and combat severe disease in infants, nevertheless there is a global effort in the development of vaccines and new generation of MAb. In this sense, RSV surveillance is essential to estimate the burden of RSV infection, evaluate the impact of preventive measures and to support public health decisions. Following European recommendations, a nationwide hospital-based RSV sentinel network denominated VIGIRSV was set up in Portugal. The aim of this work is to describe the implementation of VIGIRSV and report preliminary results obtained in this surveillance. VIGIRSV was implemented in 2021 with the initiative of the National Institute of Health Dr.outor Ricardo Jorge (INSA) and the Portuguese Paediatrics Society (PPS), and in 2023, 20 Hospitals collaborate in the surveillance. The surveillance is based on the recruitment of children <2 years-old hospitalized for, at least, 24 hours, that fulfill the case definition fordue to an RSVAcute Respiratory Infection (ARI). At recruitment, the paediatrician fills an epidemiological clinical questionnaire, and biological samples are collected for laboratorial diagnosis. Positive samples for RSV are forwarded to INSA for complementary virological analyses such as genetic characterization of the virus. Preliminary results from the first 2 years of surveillance are presented in table 1 and show an early RSV activity with high intensity in the 2022/23 season.. The data obtained from VIGIRSV´s results integrate the weekly published “Epidemiological surveillance bulletin of Influenza and other respiratory viruses” which can be foundavailable at https://www.insa.min-saude.pt/category/informacao-e-cultura-cientifica/publicacoes/atividade-gripal/, as well as the surveillance at European level. In addition, epidemiological and virological results are disclosed in scientific publications. The maintenance of such important surveillance is possible due to effort of distinct organizations and professionals, and has impact on the public health service.pt_PT
dc.description.versionN/Apt_PT
dc.identifier.urihttp://hdl.handle.net/10400.18/9059
dc.language.isoengpt_PT
dc.peerreviewednopt_PT
dc.publisherInstituto Nacional de Saúde Doutor Ricardo Jorge, IP.pt_PT
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/pt_PT
dc.subjectHuman Respiratory Syncytial Viruspt_PT
dc.subjectRSVpt_PT
dc.subjectVigiRSVpt_PT
dc.subjectEstados de Saúde e de Doençapt_PT
dc.subjectInfecções Respiratóriaspt_PT
dc.subjectPortugalpt_PT
dc.titleImplementation of a Nationwide Surveillance Network of Respiratory Syncytial Virus in Children < 2 years old in Portugalpt_PT
dc.typeother
dspace.entity.typePublication
oaire.citation.conferencePlaceLisboa, Portugalpt_PT
oaire.citation.title41st Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID 2023)pt_PT
person.familyNameMelo
person.familyNameTorres
person.familyNameGaio
person.familyNameRodrigues
person.familyNameGuiomar
person.givenNameAryse Martins
person.givenNameAna Rita
person.givenNameVânia
person.givenNameAna Paula
person.givenNameRaquel
person.identifier.ciencia-id6A11-17A6-1790
person.identifier.ciencia-idA71A-17AF-30C7
person.identifier.ciencia-idAE10-5FAB-7439
person.identifier.orcid0000-0002-6655-8715
person.identifier.orcid0000-0003-0486-647X
person.identifier.orcid0000-0001-7626-4991
person.identifier.orcid0000-0003-2264-4723
person.identifier.orcid0000-0002-4563-6315
person.identifier.scopus-author-id56080468200
rcaap.rightsopenAccesspt_PT
rcaap.typeotherpt_PT
relation.isAuthorOfPublication4e4a43a9-1c7b-4690-a976-98c003a89bf4
relation.isAuthorOfPublication930d1702-a313-4c1e-8ed2-7e2b47f1a3a3
relation.isAuthorOfPublication59791814-187c-4b34-b3a2-6ad67a213814
relation.isAuthorOfPublicationc23c6d96-e605-424f-abbb-64d783c73939
relation.isAuthorOfPublication9743082d-bed6-4e5e-94f5-1d27bb037bb0
relation.isAuthorOfPublication.latestForDiscovery59791814-187c-4b34-b3a2-6ad67a213814

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Poster_vf_atualização de apresentador.pdf
Size:
692.2 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: